CSCIF · COSCIENS Biopharma Inc.
Market Cap
$4.96M
Shares
996,166
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Diluted EPS
-$29.43
+44.9%
FY2025
Operating Cash Flow
-$8.47M
+41.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $2.95M | $8.3M | $2.04M | $1.37M | $6.57M | $1.51M | $1.84M | $2.93M | $10.7M | $16.5M | $17.23M | |
| — | — | — | $30K | $23K | — | — | — | — | — | — | — | |
| $2.16M | — | — | $5.5M | $2.84M | $7.27M | $5.89M | $6.62M | $8.89M | $8.2M | $7.15M | $11.31M | |
| — | $1.19M | $1.61M | $1.44M | $1.47M | $144K | $232K | $18K | $60K | $138K | $195K | $271K | |
| — | $168K | $129K | $136K | $143K | — | — | — | — | — | — | — | |
| — | -$10.35M | -$15.23M | -$4.37M | $4.53M | -$8.48M | -$4.72M | -$6.23M | $9.64M | -$20.28M | -$24.96M | -$50.23M | |
| — | $10K | $84K | -$885K | $1.08M | -$109K | $395K | -$188K | $5.45M | -$3.48M | $0 | $0 | |
| USD/shares | — | -$29.43 | -$53.37 | -$17.01 | $16.83 | -$16.38 | -$4,744.07 | -$13,347.46 | $9,533.90 | -$42,711.86 | -$91,906.78 | — |
| USD/shares | — | -$29.43 | -$53.37 | -$17.01 | $16.74 | -$16.38 | -$4,744.07 | -$13,347.46 | $9,152.54 | -$42,711.86 | -$91,906.78 | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.